Publications

All our publications

*Listed are the articles found in the PubMed database.

Publications by “Agueda González Rodríguez”

Moderate increase of MET in hepatocytes protects against cholestatic liver injury by promoting an effective antioxidant response.

González-Corralejo, C, García-Sáez, J, Figueroa-Fuentes, M, Addante, A, Roncero, C, Lazcanoiturburu, N, Pacheco, B, Sanz, J, Gato, C, Fernández-Calderón, E, López, MO, González-Rodríguez, Á , Porras, A, Maina, F, Fabregat, I, Herrera, B, Sánchez, A.

Validation of BMP8A fibrosis score to identify patients with metabolic dysfunction-associated steatohepatitis with advanced liver fibrosis.

Isaza, SC, Fernández-García, CE, Rojo, D, Iruzubieta, P, Ampuero, J, Aller, R, Campo, RV, Izquierdo-Sánchez, L, Fuertes-Yebra, E, Marañón, P, Banales, JM, Pagés, L, Jiménez-González, C, Cía, JR, Olaizola, I, Gómez-Camarero, J, Arroyo-Lopez, V, Romero-Gómez, M, Crespo, J, Pericàs, JM, García-Monzón, C, González-Rodríguez, Á , , .

Normalization of Oxygen Levels Induces a Metabolic Reprogramming in Livers Exposed to Intermittent Hypoxia Mimicking Obstructive Sleep Apnea.

Hernández-García, MÁ, Aldave-Orzáiz, B, Fernández-García, CE, Fuertes-Yebra, E, Rey, E, Berlana, Á , Farré, R, García-Monzón, C, Almendros, I, Landete, P, González-Rodríguez, Á .

Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.

Real Martinez, Y, Fernandez-Garcia, CE, Fuertes-Yebra, E, Calvo Soto, M, Berlana, A, Barrios, V, Caldas, M, Gonzalez Moreno, L, Garcia-Buey, L, Molina Baena, B, Sampedro-Nuñez, M, Beceiro, MJ, García-Monzón, C, González-Rodríguez, Á .

Potential protective role of let-7d-5p in atherosclerosis progression reducing the inflammatory pathway regulated by NF-κB and vascular smooth muscle cells proliferation.

Aroca-Esteban, J, Souza-Neto, FV, Aguilar-Latorre, C, Tribaldo-Torralbo, A, González-López, P, Ruiz-Simón, R, Álvarez-Villareal, M, Ballesteros, S, de Ceniga, MV, Landete, P, González-Rodríguez, Á , Martín-Ventura, JL, de Las Heras, N, Escribano, Ó, Gómez-Hernández, A.

Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.

Gallego-Durán, R, Ampuero, J, Maya-Miles, D, Pastor-Ramírez, H, Montero-Vallejo, R, Rivera-Esteban, J, Álvarez-Amor, L, Pareja, MJ, Rico, MC, Millán, R, Robles-Frías, MJ, Aller, R, Rojas, Á, Muñoz-Hernández, R, Gil-Gómez, A, Gato, S, García-Lozano, M, Arias-Loste, MT, Abad, J, Calleja, JL, Andrade, RJ, Crespo, J, González-Rodríguez, Á , García-Monzón, C, Andreola, F, Pericás, JM, Jalan, R, Martín-Bermudo, F, Romero-Gómez, M.

Hospital-based screening outperforms primary care screening as a means of achieving hepatitis C virus micro-elimination.

Fernández-García, CE, Gallego-Galiana, J, Solís-Muñoz, PA, Del Pozo-Maroto, E, Domínguez-Alcón, L, Tobar-Izquierdo, M, Sáez, A, Rodríguez de Cía, J, Magaña-Sánchez, A, Real-Martínez, Y, García-Buey, L, González-Moreno, L, Caldas-Álvarez, M, Cardeñoso-Domingo, LM, González-Gamarra, A, Salvador-Calvo, A, González-Rodríguez, Á , García-Monzón, C.

Editorial: mitochondrial respiratory chain activity-a potential link with disease severity and treatment response in alcoholic hepatitis. Authors' reply.

Solís-Muñoz, P, de la Flor-Robledo, M, Fernández-García, CE, González-Rodríguez, Á , García-Monzón, C.

Mitochondrial respiratory chain activity is associated with severity, corticosteroid response and prognosis of alcoholic hepatitis.

Solís-Muñoz, P, de la Flor-Robledo, M, García-Ruíz, I, Fernández-García, CE, González-Rodríguez, Á , Shah, N, Bataller, R, Heneghan, M, García-Monzón, C, Solís-Herruzo, JA.

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.

Marañón, P, Fernández-García, CE, Isaza, SC, Rey, E, Gallego-Durán, R, Montero-Vallejo, R, de Cía, JR, Ampuero, J, Romero-Gómez, M, García-Monzón, C, González-Rodríguez, Á .

Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.

Cruces-Sande, M, Vila-Bedmar, R, Arcones, AC, González-Rodríguez, Á , Rada, P , Gutiérrez-de-Juan, V, Vargas-Castrillón, J, Iruzubieta, P, Sánchez-González, C, Formentini, L, Crespo, J, García-Monzón, C, Martínez-Chantar, ML, Valverde, ÁM , Mayor, F, Murga, C.

A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.

Valdecantos, MP , Pardo, V , Ruiz, L , Castro-Sánchez, L, Lanzón, B, Fernández-Millán, E, García-Monzón, C, Arroba, AI , González-Rodríguez, Á , Escrivá, F, Álvarez, C, Rupérez, FJ, Barbas, C, Konkar, A, Naylor, J, Hornigold, D, Santos, AD, Bednarek, M, Grimsby, J, Rondinone, CM, Valverde, ÁM .

Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis.

López-Luque, J, Caballero-Díaz, D, Martinez-Palacián, A, Roncero, C, Moreno-Càceres, J, García-Bravo, M, Grueso, E, Fernández, A, Crosas-Molist, E, García-Álvaro, M, Addante, A, Bertran, E, Valverde, AM , González-Rodríguez, Á , Herrera, B, Montoliu, L, Serrano, T, Segovia, JC, Fernández, M , Ramos, E, Sánchez, A, Fabregat, I.

C/ Arturo Duperier 4 | 28029 Madrid (España) | Teléfono +(34) 91 585 4400 | Código DIR3: EA0041362